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1. Introduction 
Toxoplasma gondii is an obligate intracellular protozoan that infects one-third of the world 
population. Asymptomatic in immunocompetent hosts, toxoplasmosis has severe 
consequences in immunosuppressed individuals and can even lead to death.1,2 Congenital 
toxoplasmosis causes development of sequelae later in life, including chorioretinitis, hearing 
loss or mental retardation.3 Toxoplasma gondii is also recognized as being a major cause of 
abortion in farm animals, such as sheep and goats thus causing substantial reproductive and 
economic losses.4 Additionally, these infected animals are a parasitic reservoir involved in 
human contamination. Recently it has been reported that Toxoplasma gondii has some degree 
of causal relation to Schizophrenia5 because of the positive relationships between the 
prevalence of Toxoplasma antibodies and the development of schizophrenia. A recent article 
reports that Toxoplasma infection in rodents blocks the aversion toward predator odors and 
develop an attraction suggesting an integrating effect of the parasite.6 This study provides 
an example of the behavioral effects of Toxoplasma in models of psychiatric and emotional 
conditions.  
Once human beings or animals have been infected, no drug treatment available at present 
will eliminate the parasite. Nor is there any vaccine for human use to control the disease.  
Primary infection with T. gondii results in the setting of both humoral and cell-mediated 
immune responses and confers long-term protection. This suggests that the development of 
an efficient vaccine is a realistic goal. Moreover because of the enormous estimated costs 
and social impact of T. gondii infection and the fact that primary infection with this parasite 
could give the host a protective immunity against re-infection, many studies have 
investigated possible solutions for an efficient vaccine.7,8 However the immune response set 
following a T. gondii infection firstly needs to be clearly defined before a vaccine can be 
developed.  
Host resistance seems to occur via synthesis of IFN- by NK cells and adaptive T 




which induce NK cells to secrete IFN-. The combined action of IL-12 and IFN- induce a 
strong differentiation of T helper precursors into Th1 lymphocytes. These CD4+ T cells then 
synthesize large amounts of IFN- and IL-2. These two cytokines finally induce CD8+ T 
lymphocytes proliferation and IFN- secretion.10 Thus protection against T. gondii infection 
is mainly attributed to cell-mediated immunity.  
Previous studies have shown that both CD4+ and CD8+ T-cell subtypes are involved in the 
protection and the relative contribution of these two populations was investigated by 
adoptive transfer or in vivo depletion.10 The transfer of T cells from infected or immunized 
mice to naïve mice provided protection against a lethal challenge of T. gondii, but this 
protection was abolished by depletion of CD8+ T cells prior to transfer but not by depletion 
of CD4+ T cells11,12. Similarly, transfer of CD8+ T cells from chronically infected mice to 
naïve WT or nude mice was also able to provide protection from T. gondii challenge11. 
However, in response to T. gondii, the lack of CD8+ T cells could be compensate by a potent 
NK cell response, though ┚2-m-deficient mice remained more susceptible than WT mice.13 
All these data suggest a prominent role of CD8+ cells with a supporting role for CD4+ cells 
during the acute phase as well as during the chronic phase of infection. 
CD8+ T lymphocytes mediated protection by IFN-┛ which has been demonstrated to be 
crucial by studies using neutralizing antibody to IFN-┛ or mice deficient in its production 14, 
15, 16. Evidence that production of this cytokine and subsequent protection against 
toxoplasmosis is dependent on CD8+ T cells was demonstrated by showing that treatment of 
infected mice with anti-CD8 antibodies resulted in reduced production of IFN-┛ and loss of 
IFN-┛-mediated protection. 17, 18 CD8+ T cells can also mediate perforin-dependent 
cytotoxicity against target cells that present the correct peptide in the context of MHC on 
their cell surface. Several studies have shown that CD8+ T cells isolated from immunized or 
infected mice lysed infected cells or targets pulsed with Toxoplasma antigens19,20, 21,22. All 
these data suggest a prominent role of CD8+ cells during the acute phase as well as during 
the chronic phase of infection.  
If IFN- is the major cytokine of resistance to T. gondii, IL-12 is a crucial initiation cytokine to 
trigger an efficient cell-mediated immunity. Indeed, IL-12 is a major cytokine secreted in 
response to T. gondii by neutrophils23, macrophages24, plasmacytoid dendritic cells (pDCs) 25, 
conventional dendritic cells (cDCs) 26 and the subset of cDCs expressing CD827. Recently 
Mashayekhi et al have demonstrated the critical role of CD8+ DCs for activation of innate 
immunity through IL-12 production during T. gondii infection and have shown that CD8+ 
DCs are the only cells whose IL-12 production is required to control acute infection28.  
IL-12 is produced in response to Toll-like receptor (TLR) recognition of molecular structures 
broadly conserved across microbial species29 that triggers the early IFN- secretion following 
T. gondii infection. IFN- activates various cell-intrinsic antiparasitic defense defense 
pathway within infected cells for intracellular elimination of Toxoplasma, including the 
activation of interferon-regulated GTPases (IRGs)30,31, induction of reactive nitrogen 
intermediates32, tryptophan degradation in human cells33, and autophagy34,35. 
So DCs are the first producers of IL-12 in response to T. gondii antigens and several previous 
studies suggest that DCs play an important role in the setting of the immune response to the 
intracellular parasite T. gondii during the early and chronic phases of infection.  
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The central role of DCs in controlling immunity makes these cells ideal tools for priming 
functional immune responses. Many studies have proposed the use of DCs as vaccine 
vectors. For instance, T. gondii extract-pulsed splenic DCs administered in vivo induce a 
strong humoral and cellular immune response and promote protection against a virulent 
challenge.36, 37 It has been also observed that Toxoplasma pulsed DCs induced protective 
immunity against T. gondii infection in both syngeneic and allogeneic mouse models. This 
protection was associated with the induction of humoral and cellular Toxoplasma-specific 
responses38. However, expensive treatments of this type, based on living cells, could be 
envisaged only for severe diseases, such as cancers, which are specific to the individual due 
to MHC restriction. For ethical reasons, it is not possible to use live cell lines in an 
immunisation protocol in humans. New approaches, involving the development of non-live 
and DNA-free vaccines, must therefore be pursued. Moreover, the use of DCs is limited by 
the difficulty of obtaining large numbers of cells suitable for vaccination purposes.  
If DCs can effectively process T. gondii antigens for presentation in vivo, their use in a 
vaccine strategy is not acceptable. It is of interest to study the effector mechanisms induced 
by T. gondii-sensitized dendritic cells as a well-described protective immune response would 
help the development of new efficient vaccine strategies.  
So the relative contribution of two main lymphocytic populations, CD4+ and CD8+, was 
investigated in a model of chronically infected mice, following dendritic cell vaccination and 
lymphocyte depletion.  
We first determined the role of CD4+ T lymphocytes after an efficient depletion of over 90%. 
The results revealed a minor role for these cells since CD4-depleted or non depleted mice 
have similar cytokine secretion profiles in spleen as well as in MLNs. Moreover, depleted 
mice did not show any significant loss of protection in terms of brain cyst load. These results 
contrast with those obtained by Casciotti in 2002.10 They demonstrated that CD4+ T cells are 
important for early IFN- production during T. gondii infection and that lack of CD4+ 
lymphocytes leads to parasite multiplication in the tissues. Moreover CD4 deficient mice 
exhibited parasite burdens in the brain. Johnson and Sayles also showed the implication of 
CD4+ cells as they induce CD8+ T cells through the production of IL-2 and maintain CD8+ 
T cells effector immunity.39 CD4+ T lymphocytes also contributed significantly to protection 
against chronic infection via their role as helper cells for production of isotype-switched 
antibodies. The contradictory results obtained following infection alone or following 
vaccination plus infection could result from a particular orientation of the immune response. 
Indeed, in our protocol dendritic cells could directly prime CD8+ T lymphocytes via cross-
presentation of T. gondii antigens, as previously demonstrated by Gubbels et al.40 
So CD4+ T lymphocytes appeared to be not implicated either in spleen or mesenteric lymph 
node cytokine secretion or in long-term protection of mice.  
We next studied the implication of CD8+ T lymphocytes after an efficient depletion of over 
90%. In spleens CD8+ cells seem to be responsible for cytokine synthesis. Indeed, their 
depletion leads to a significant decrease of both Th1 (IFN- and IL-2) and Th2 (IL-10 and IL-
4) cytokines. We further confirmed these data by identifying the CD8+ T cells as the IFN--
producing cells. These results are in accordance with another vaccination assay where 
Gazzinelli et al. got similar results. They vaccinated BALB/c mice with the mutant T. gondii 




a lethal dose of tachyzoites. They identified IFN--producing CD8+ T cells as the major 
effectors of immunity in vivo.41 Moreover, in our experiment, CD8+ cells depletion induced a 
loss of protection in mice previously immunized with pulsed dendritic cells, so CD8+ cells 
are crucial for CBA/J mice resistance to T. gondii infection. CD8+ cells also appear to play a 
major role in Trypanosoma cruzi infection. Mice lacking CD8+ T-cell function fail to control a 
normally non-lethal infection and die early in the acute phase. Moreover, depletion of CD8+ 
T cells in the chronic phase results in increased parasite load.42 
In contrast to spleens, MLNs showed increased secretions of cytokines following CD8+ 
depletion suggesting that CD8+ T lymphocytes could act as regulatory cells. A recent review 
summarizes the current knowledge on CD8+ Tregs, a newly described CD8+ lymphocyte 
subtype with dedicated suppressor function.43 Although not proven in parasitic infections, 
their importance in autoimmunity is well-documented and they could be responsible for the 
moderation of the immune response set in local lymph nodes. It would be of importance to 
determine which cell population is responsible for the MLN IFN- secretion. It has been 
demonstrated that splenic NK cells could produce this cytokine in response to T. gondii in 
MHC-I deficient mice thus unable to activate CD8+ T cells.44 
So CD8+ T lymphocytes appeared as the main effectors, inducing a strong Th1 response in 
spleen while inhibiting both Th1 and Th2 responses in mesenteric lymph nodes.  
This is the first study to point to CD8+ lymphocytes as the unique effector population 
responsible for the protection of mice following efficient DC vaccination and subsequent 
virulent challenge. This is partly in accordance with a previous description of CD8+ T cells 
as effector lymphocytes while CD4+ T cells were crucial for the regulation of the immune 
response in a very different vaccination assay.17 
We provide further insight into the long-term immunity that protects mice against T. gondii, 
a ubiquitous parasite resulting in severe sequelae in immunocompromised individuals. 
Future studies will be needed to determine how T. gondii antigens are presented to CD8+ 
lymphocytes. A recent study showed encouraging results. Indeed, the authors demonstrated 
that CD8+ DCs were very efficient in processing and cross-presenting exogenous antigen to 
CD8+ T cells. They also highlighted CD24 as an essential co-stimulatory molecule required 
for CD8+ DCs to generate CD8+ and CD4+ T-cell responses.45 The possible roles of various 
CD4+ lymphocyte subtypes and other immune cell populations during the chronic phase of 
the disease also need to be elucidated, with a view to developing an effective vaccine to be 
used in animals that serve as a natural reservoir for human contamination. 
Finally, the next step to efficiently develop a vaccine strategy will be to identify which 
parasitic peptides are cross-presentated by DCs to CD8+ T cells to initiate the specific 
protective response to T. gondii. Blanchard et al. recently found that a decapeptide from the 
dense granule protein GRA6 could effectively induce such protection against T. gondii, as 
assessed by survival of mice.46 However, their study was conducted using bone marrow-
derived DCs. It could be of interest to target in vivo splenic CD8+ DCs, known to protect our 
mice, with such putative protective parasitic peptides. 
Fully dissecting the cellular and molecular events leading to this protective response will 
allow for better design of vaccine strategies to enhance immunity and decrease morbidity 
and mortality associated with Toxoplasma infection. 
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Thus, transfer of Toxoplasma antigens to lymphoid resident DCs is a feature of DC 
vaccination that can be exploited to improve vaccine outcome. 
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